This slideshow reviews drug information for ZYTIGA® (abiraterone acetate).
This slideshow reviews drug information for BOSULIF® (bosutinib).
This slideshow reviews drug information for ICLUSIG™ (ponatinib).
This slideshow reviews drug information for STIVARGA® (regorafenib).
This slideshow reviews drug information for MARQIBO® (vinCRIStine sulfate LIPOSOME injection)
This slideshow reviews drug information for SYNRIBO™ (omacetaxine mepesuccinate).
This slideshow reviews drug information for XTANDI® (enzalutamide).
This slideshow reviews drug information for COMETRIQ™ (cabozantinib).
This slideshow reviews ABRAXANE® Injectable Suspension (paclitaxel protein-bound particles) (albumin-bound) for patients with non-small cell lung cancer.
This slideshow reviews drug information for KADCYLA™ (ado-trastuzumab emtansine).
Compared to the severe adverse effects of chemotherapy, chemotherapy-induced alopecia (CIA) is surprisingly one of the more troubling aspects of ...
Colorectal cancer is the 3rd most common cancer, and the 2nd most common cause of death in the United States. ...
Retinoblastoma is a rare cancer that is caused by a mutation in the retinoblastoma gene (RB1) controlling cell division of ...
Ewing sarcoma is one of a group of cancers known collectively as the Ewing sarcoma family of tumors. Despite the ...
Breast cancer is the most commonly diagnosed cancer among women in the U.S. besides skin cancer. About 1 in 8 ...
More people in the United States die from lung cancer than any other type of cancer. This is true for ...
Melanoma is the most dangerous type of skin cancer, and the most deadly. It begins in the melanocytes, but may ...
The incidence of cancer diagnoses is increasing worldwide as the world’s population grows and people continue to live longer. As ...
More than 40% of patients undergoing chemotherapy develop some degree of mucositis during the course of their treatment. Patients receiving ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|